Supplementary Materialsijms-19-03693-s001. checkpoint acquired a negligible effect on anti-tumor immunity and TAMs repolarization. Our results demonstrate a benefit of combined immunotherapy comprising the activation of both adaptive and innate immunity in the treatment of tumors with reduced MHC-I manifestation. 0.05, 31 days after inoculation of tumor cells). Additionally, in two immunized mice treated with either… Continue reading Supplementary Materialsijms-19-03693-s001. checkpoint acquired a negligible effect on anti-tumor immunity and